Merck & Co MRK releases its next round of earnings this Friday. Here's Benzinga's essential guide to Merck's Q2 earnings report.
Earnings and Revenue
Merck EPS will likely be near $1.03 while revenue will be around $10.29 billion, according to analysts.
In the same quarter last year, Merck posted EPS of $1.01 on sales of $9.93 billion. The Wall Street estimate would represent a 1.98 percent increase in the company's earnings. Sales would be up 3.63 percent on a year-over-year basis. Merck & Co's reported EPS has stacked up against analyst estimates in the past like this:
Quarter | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 |
EPS Estimate | 0.99 | 0.93 | 1.03 | 0.87 |
EPS Actual | 1.05 | 0.98 | 1.11 | 1.01 |
Stock Performance
Over the last 52-week period, shares are up 3.07 percent. Given that these returns are generally positive, long-term shareholders can relax going into this earnings release. Long-term shareholders are already enjoying 12-month gains prior to the announcement.
Analyst estimates have adjusted higher for EPS and revenues over the past 90 days. The average rating by analysts on Merck stock is a Neutral. The strength of this rating has maintained conviction over the past 90 days.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.